Currently, Repligen Corp [RGEN] is trading at $120.23, up 1.30%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RGEN shares have gain 3.49% over the last week, with a monthly amount glided 7.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Barclays started tracking the stock with Overweight rating on June 24, 2025, and set its price target to $150. On April 29, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $160 on the stock. Evercore ISI started tracking the stock assigning a In-line rating and suggested a price target of $155 on March 18, 2025. TD Cowen initiated its recommendation with a Buy and recommended $200 as its price target on February 10, 2025. Canaccord Genuity started tracking with a Hold rating for this stock on December 17, 2024, and assigned it a price target of $165. In a note dated November 14, 2024, Wolfe Research initiated an Peer Perform rating.
This stock has fluctuated between a low of $102.96 and a high of $182.52 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $205 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $120.23 at the most recent close of the market. An investor can expect a potential return of 70.51% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp [NASDAQ:RGEN] were 673.96M which represents 14.81% growth. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 117.62 points at the first support level, and at 115.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 122.77, and for the 2nd resistance point, it is at 125.31.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp [NASDAQ:RGEN] is 8.59. Also, the Quick Ratio is 7.32, while the Cash Ratio stands at 5.76. Considering the valuation of this stock, the price to sales ratio is 10.04, the price to book ratio is 3.28.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Sep 10 ’25 when 29111.0 shares were purchased. Director, Madaus Martin D completed a deal on Aug 08 ’25 to buy 1800.0 shares. Meanwhile, Director Hunt Anthony sold 26447.0 shares on May 15 ’25.
